sialorrhea/scopolamină

Linkul este salvat în clipboard

Alegeți tipul de sortare

Pagină 1 din 51 rezultate

Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital

Numai utilizatorii înregistrați pot traduce articole

Background: Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this

Transdermal scopolamine in drooling.

Numai utilizatorii înregistrați pot traduce articole

The effect of oral anticholinergic drugs has been limited in the treatment of drooling. Transdermal scopolamine (1.5 mg/2.5 cm2) offers advantages. One single application is considered to render a stable serum concentration for 3 days. A distinct reduction of basal salivation was demonstrated in an

Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series.

Numai utilizatorii înregistrați pot traduce articole

Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0- 97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study

The use of transdermal scopolamine to control drooling. A case report.

Numai utilizatorii înregistrați pot traduce articole

Drooling is a serious social handicap experienced by some neurologically impaired patients. No one method has been identified to control drooling for all patients, however, anticholinergic drugs recently have been utilized. In the case study described, transdermal scopolamine patches were found to

Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND This study investigated the efficacy of scopolamine (an anticholinergic agent) ointment against clozapine-induced hypersalivation. METHODS The patients enrolled in this study consisted of 10 clozapine-treated schizophrenia patients and 10 healthy adult men. A prospective, randomized,

Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND Sialorrhea is a distressing symptom accompanying oral cancer and many heterogeneous cancer-related conditions (chemotherapy-induced nausea, bowel subocclusion, pharmacologic side effects), but its incidence is low in cancer patients. Conversely, it is frequent in patients with

Management of drooling in disabled patients with scopolamine patches.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE To evaluate the efficacy of scopolamine administered transdermally for the treatment of drooling in severely disabled patients. METHODS A prospective, randomized, double-blind, crossover, placebo-controlled clinical trial was designed. The study group consisted of 30 handicapped patients

Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Numai utilizatorii înregistrați pot traduce articole

Ten developmentally delayed children with excessive drooling were randomized in a double-blind, placebo-controlled study to assess the efficacy and safety of transdermal scopolamine. Over half of the patients had a statistically significant reduction in drooling, and one-third had cessation of

Treatment of drooling with scopolamine in pediatric ICU: A case series report.

Numai utilizatorii înregistrați pot traduce articole

Drooling is a condition that affects patients with difficulties in swallowing, being common in patients with mental, neurological or dysphagic deficiency. This condition is difficult to diagnose, as it is often confused with sialorrhea, and in many cases we have a hyposalivation scenario. Its

Control of drooling with transdermal scopolamine in a child with cerebral palsy.

Numai utilizatorii înregistrați pot traduce articole

Transdermal scopolamine patches (1.5 mg) were used to control drooling in a two-year-old boy with severe spastic quadriparetic cerebral palsy and developmental delay. He responded well to the continuous scopolamine therapy, with a decrease in drooling, and a secondary decrease in respiratory

Control of drooling using transdermal scopolamine skin patches. A case report.

Numai utilizatorii înregistrați pot traduce articole

Transdermal scopolamine has been shown to be very useful in the management of drooling, particularly in patients with neurological or neuropsychiatric disturbances or severe developmental disorders. In this paper, we present the case of a 24-year-old patient with a diagnosis of cerebral palsy and a

Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.

Numai utilizatorii înregistrați pot traduce articole

[A scopolamine plaster behind the ear to prevent drooling?].

Numai utilizatorii înregistrați pot traduce articole

[Control of drooling with scopolamine ointment for severely disabled].

Numai utilizatorii înregistrați pot traduce articole

[Scopolamine against hypersalivation].

Numai utilizatorii înregistrați pot traduce articole

Anterior
1
2
3
4
Următor →

Alăturați-vă paginii
noastre de facebook

Herbal & Natural Medicine

Cea mai completă bază de date cu plante medicinale susținută de știință

Funcționează în 55 de limbi
Cure pe bază de plante susținute de știință
Recunoașterea ierburilor după imagine
Harta GPS interactivă - etichetați ierburile în locație (în curând)
Citiți publicațiile științifice legate de căutarea dvs.
Căutați plante medicinale după efectele lor
Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate